Browse by all authors Browse By Author ID - Burmeister, Bryan

Browse Results (111 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

Page 1 of 3

Result Pages:    1 2 3  next › last »

Refine

  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Smithers, B. Mark, Devitt, Peter, Jamieson, Glyn G., Bessell, Justin, Gotley, David, Gill, P. Grantley, Neely, Mervyn, Joseph, David J., Yeoh, Eric K., Burmeister, Bryan and Denham, James W. (1997) A combined modality approach to the management of oesophageal cancer. European Journal of Surgical Oncology, 23 3: 219-223. doi:10.1016/S0748-7983(97)92364-7 35   17 Cited 19 times in Scopus19 0
McLachlan, S., Fisher, R., McClure, B., Beresford, J., McKendrick, J., Mackay, J., Solomon, M., Burmeister, B., Hartopeanu, C. and Ngan, S. (2008). A comparison of quality of life in patients with T3 rectal cancer receiving short course versus long course preoperative radiation. A Trans-Tasman Radiation Oncology Group Trial (TROG 01.04). In: Journal of Clinical Oncology. , , (). . 20   0
Lim, K. H., Thomas, J., Brown, W. A., Harvey, J., Burmeister, B., Walpole, E., Thomson, D., Martin, I., Gotley, D. C. and Smithers, B. M. (2003). A comparison of treatment outcome between adenocarcinoma and squamous cell carcinoma of the eosophagus. In: ANZ Journal of Surgery. -, -, (A63-A63). -. doi:10.1111/j.1445-2197.2003.00009.x 135   0
Ngan, S., Fisher, R., Mackay, J., Solomon, M., Burmeister, B., Goldstein, D., Schache, D., Joseph, D., Ackland, S. and McClure, B. (2007). Acute adverse events in a randomised trial of short course versus long course preoperative radiotherapy for T3 adenocarcinoma of rectum: a Trans-Tasman Radiation Oncology Group trial (TROG 01.04). In: Ejc Supplements. 14th European Cancer Conference (ECCO 14), Barcelona Spain, (237-237). Sep 23-27, 2007. doi:10.1016/S1359-6349(07)70936-9 14   5 0
Burmeister, Bryan, Henderson, Michael and Thompson, John (2012) Adjuvant nodal irradiation in melanoma Reply. Lancet Oncology, 13 8: E327-E327. doi:10.1016/S1470-2045(12)70330-3 14   0 Cited 0 times in Scopus0 0
Henderson, M. A., Burmeister, B., Thompson, J. F., Di Iulio, J., Fisher, R., Hong, A., Scolyer, R., Shannon, K., Hoesktra, H. and Ainslie, J. (2009). Adjuvant radiotherapy and regional lymph node field control in melanoma patients after lymphadenectomy: Results of an intergroup randomized trial (ANZMTG 01.02/TROG 02.01). In: Journal of Clinical Oncology. 45th Annual Meeting of the American-Society-of-Clinical-Oncology, Orlando Fl, (). May 29-Jun 02, 2009. 20   0
Burmeister, B., Henderson, M., Thompson, J., Fisher, R., Di Iulio, J., Smithers, M., Hong, A., Carruthers, S., Hoekstra, H. and Ainslie, J. (2009). Adjuvant Radiotherapy Improves Regional (Lymph Node Field) Control in Melanoma Patients after Lymphadenectomy: Results of an Intergroup Randomized Trial (TROG 02.01/ANZMTG 01.02). In: Proceedings of the American Society for Radiation Oncology 51st Annual Meeting, 51st Annual Meeting of the American Society for Radiation Oncology. 51st Annual Meeting of the American-Society-for-Radiation-Oncology, Chicago, IL, (S2-S2). 1-5 November 2009. 342   7
Burmeister, Bryan H., Henderson, Michael A., Ainslie, Jill, Fisher, Richard, Di Iulio, Juliana, Smithers, B. Mark, Hong, Angela, Shannon, Kerwin, Scolyer, Richard A., Carruthers, Scott, Coventry, Brendon J., Babington, Scott, Duprat, Joao, Hoekstra, Harald J. and Thompson, John F. (2012) Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial. Lancet Oncology, 13 6: 589-597. doi:10.1016/S1470-2045(12)70138-9 136   46 Cited 56 times in Scopus56 5
Purcell, A., Fleming, J., Bennett, S., McGuane, K., Burmeister, B. and Haines, T. (2010) A multidimensional examination of correlates of fatigue during radiotherapy. Cancer, 116 2: 529-537. doi:10.1002/cncr.24731 89   8 Cited 8 times in Scopus8 0
Foote, Matthew C., Burmeister, Bryan H., Thomas, Janine and Smithers, B. Mark (2010) A novel treatment for metastatic melanoma with intralesional rose bengal and radiotherapy: A case series. Melanoma Research, 20 1: 48-51. doi:10.1097/CMR.0b013e328331caa2 89   10 Cited 14 times in Scopus14 1
Burmeister, B., Walpole, E., D'Arcy, N., Burmeister, E.A., Cox, S., Thomson, D.B., Harvey, J. and Smithers, B.M. (2009) A phase II trial of chemoradiation therapy with weekly oxaliplatin and protracted infusion of 5-fluorouracil for esophageal cancer. Investigational New Drugs, 27 3: 275-279. doi:10.1007/s10637-008-9178-4 71   6 Cited 7 times in Scopus7 0
Burmeister, B. H., Fielding, D. I., Ramsay, J. R., Baumann, K. C., Dauth, M. and Walpole, E. T. (2005) A phase I study of moderate-dose radiation therapy and weekly gemcitabine in patients with locally advanced non-small cell lung cancer not suitable for radical chemoradiation therapy. Clinical Oncology, 17 5: 332-336. doi:10.1016/j.clon.2005.03.013 57   4 Cited 5 times in Scopus5 0
Burmeister, Bryan H., Smithers, B. Mark, Burmeister, Elizabeth, Baumann, Kathryn, Davis, Sidney, Krawitz, Hedley, Johnson, Carol and Spry, Nigel (2006) A prospective phase II study of adjuvant postoperative radiation therapy following nodal surgery in malignant melanoma - Trans Tasman Radiation Oncology Group (TROG) Study 96.06. Radiotherapy and Oncology, 81 2: 136-142. doi:10.1016/j.radonc.2006.10.001 154   38 Cited 47 times in Scopus47 0
Burmeister, B. H., Smithers, B. M., Burmeister, E. A., Baumann, K. C., Davis, S. R., Krawitz, H., Johnson, C. and Spry N. (2005). A prospective phase II study of postoperative radiation therapy following nodal surgery for malignant melanoma – Trans Tasman Radiation Oncology Group (TROG) study 96.06. In: Asia-Pacific Journal of Clinical Oncology: Clinical Oncological Society of Australia 32nd Annual Scientific Meeting 2005. Clinical Oncological Society of Australia 32nd Annual Scientific Meeting 2005, Brisbane, Australia, (26-26). 16-18 November 2005. doi:10.1111/j.1743-7563.2005.00027.x 172   0
Bydder, S., Spry, N.A., Christie, D.R.H., Roos, D., Burmeister, B., Krawitz, H., Davis, S., Joseph, D.J., Poulsen, M. and Berry, M. (2003) A prospective trial of short-fractionation radiotherapy for the palliation of liver metastases. Australasian Radiology, 47 3: 284-288. doi:10.1046/j.1440-1673.2003.01177.x 83   Cited 12 times in Scopus12 0
Smithers, B. M. and Burmeister, B. (2003). A randomised controlled trial of surgery alone compared with chemoradiation and surgery: A focus on surgical outcomes. In: Annals of Surgical Oncology: Abstracts of the 56th Annual Cancer Symposium of the Society-of-Surgical-Oncology. 56th Annual Cancer Symposium of the Society-of-Surgical-Oncology, Los Angeles, CA, (S10-S10). 5-9 March, 2003. doi:10.1245/s10434-006-8001-8 37   0
Michael, Michael, Burmeister, Bryan, Burmeister, Elizabeth, Cox, Sharon, Horwood, Keith, Wirth, Andrew, Sasso, Guiseppe, Forouzesh, Bahram, Lehman, Margot and Ball, David (2009). A randomised phase II study of two regimens of high dose palliative chemoradiation therapy in the management of locally advanced non-small cell lung cancer (TROG 03.07). In: 13th World Conference on Lung Cancer, San Francisco CA, (S516-S516). July 31 - August 4 2009. 22   0
Burmeister, B. H., Smithers, B. M., Thomas, J., Burmeister, E., Walpole, E., Harvey, J., Thomson, D., Barbour, A. and Gotley D. (2008). A randomised phase II trial comparing pre-operative chemotherapy with pre-operative chemoradiation therapy for localized carcinoma of the oesophagus. In: Asia-Pacific Journal of Clinical Oncology. Clinical Oncological Society of Australia and the International Association of Cancer Registries Joint Scientific Meeting, held in conjunction with the Australian and New Zealand Gastro-Oesophageal Surgery Association, Sydney, Australia, (A47-A47). 18-20 November 2008. doi:10.1111/j.1743-7563.2008.00201_1.x 107   0
Smithers, B. M., Burmeister, B. H., Fitzgerald, L., Gebski, V., Denham, J., Devitt, P., Ackland, S., Joseph, D., Millar, J., North, J., Walpole, E. and Gotley, D. (2003). A randomized controlled trial of surgery alone compared with chemoradiation & surgery: a focus on the surgical outcomes. In: 56th Annual Cancer Symposium of the Society of Surgical Oncology, Los Angeles, CA, United States, (S10-S10). 5-9 March 2003. 30   3
Burmeister, Bryan H., Smithers, Bernard M., Fitzgerald, L., Gebski, Val, Devitt, P., Ackland, Stephen, Joseph, David, Millar, J., North, J., Walpole, Euan T. and Denham, Jim W. (2002). A randomized phase III trial of preoperative chemoradiation followed by surgery (CR-S) versus surgery alone (S) for localized resectable cancer of the esophagus. In: Proceedings of the 2002 American Society Clinical Oncology Meeting. 2002 ASCO Annual Meeting, xx, (). 2002. 94  
Burmeister, Bryan H., Michael, Michael, Burmeister, Elizabeth, Cox, Sharon, Lehman, Margot, Wirth, Andrew, Horwood, Keith, Sasso, Giuseppe, Forouzesh, Barham and Ball, David (2011) A randomized phase II trial of two regimens of moderate dose chemoradiation therapy for patients with non-small cell lung cancer not suitable for curative therapy trans tasman radiation oncology study TROG 03.07. Journal of Thoracic Oncology, 6 12: 2076-2082. doi:10.1097/JTO.0b013e31822d53a9 23   1 Cited 1 times in Scopus1 1
Roos, D., Ball, D.L., Burmeister, B. and Fisher, R. (2005) Are single fractions of radiotherapy suitable for plantar fasciitis. Australasian Radiology, 49 257-257. 64  
Roos, DE, O'Brien, PC, Smith, JG, Spry, NA, Hoskin, PJ, Burmeister, BH, Turner, SL and Bernshaw, DM (2000) A role for radiotherapy in neuropathic bone pain: Preliminary response rates from a prospective trial (Trans-Tasman Radiation Oncology Group, TROG 96.05). International Journal of Radiation Oncology Biology Physics, 46 4: 975-981. doi:10.1016/S0360-3016(99)00521-0 6   23 Cited 34 times in Scopus34 0
Brown, W. A., Thomas, J., Gotley, D. C., Lim, K. H., Martin, I., Burmeister, B., Harvey, J., Walpole, E., Thomson, D. and Smithers, B. M. (2003). Assessing the response of eosophageal carcinoma to neoadjuvant therapy using oesophagogastroscopy. In: ANZ Journal of Surgery ANZ Journal of Surgery: Abstracts of the RACS Annual Scientific Congress 2003. RACS Annual Scientific Congress 2003, Brisbane, Australia, (A63-A64). 5-9 May, 2003. doi:10.1046/j.1445-2197.73.s.9.x 69   0
Hughes, Brett G. M., Yip, Desmond, Chao, Michael, Gibbs, Peter, Carroll, Susan, Goldstein, David, Burmeister, Bryan and Karapetis, Christos (2004) Audit of postoperative chemoradiotherapy as adjuvant therapy for resected gastroesophageal adenocarcinoma: An Australian multicentre experience. ANZ Journal of Surgery, 74 11: 951-956. doi:10.1111/j.1445-1433.2004.03218.x 81   13 Cited 14 times in Scopus14 0
Barbour, Andrew P., Tang, Yue Hang, Armour, Nicola, Dutton-Regester, Ken, Krause, Lutz, Loffler, Kelly A., Lambie, Duncan, Burmeister, Bryan, Thomas, Janine, Smithers, B. Mark and Hayward, Nicholas K. (2014) BRAF mutation status is an independent prognostic factor for resected stage IIIB and IIIC melanoma: implications for melanoma staging and adjuvant therapy. European Journal of Cancer, 50 15: 2668-2676. doi:10.1016/j.ejca.2014.06.009 16   0 Cited 0 times in Scopus0 0
Purcell, A., Fleming, J., Bennett, S., Burmeister, B. and Haines, T. (2008). Cancer-related fatigue intervention trial. In: Princess Alexandra Hospital Cancer Collaborative Group Meeting, Brisbane, Australia., (). 4th August. 28  
Purcell, A., Fleming, J., Bennett, S., Burmeister, B. and Haines, T. (2008). Cancer-related fatigue intervention trial. In: Queensland Health: Advancing Key Initiatives in Cancer Care, Brisbane, Australia, (). 16th May 2008. 42  
Denham, J. W., Ackland, S. P., Burmeister, B., Walpole, E., Lamb, D. S., Dady, P. and Spry, N. A. (1999) Causes for increased myelosuppression with increasing age in patients with oesophageal cancer treated by chemoradiotherapy. European Journal of Cancer, 35 6: 921-927. doi:10.1016/S0959-8049(99)00065-9 145   4 Cited 4 times in Scopus4 0
Burmeister, Bryan H., Gogna, N. Kumar, Bryant, Guy P., Armstrong, John, Kelly, Wayne, Mackintosh, John, Walpole, Euan and Morton, Karen (1999) Chemoradiation for inoperable non small cell lung cancer: A phase II study using a regimen with acceptable toxicity. Lung Cancer, 23 3: 233-240. doi:10.1016/S0169-5002(99)00010-0 74   0 0
Harvey, J. A., Bessell, J. R., Beller, E., Thomas, J., Gotley, D. C., Burmeister, B. H., Walpole, E. T., Thomson, D. B., Martin, I., Doyle, L., Burmeister, E. and Smithers, B. M. (2004) Chemoradiation therapy is effective for the palliative treatment of malignant dysphagia. Diseases of The Esophagus, 17 3: 260-265. doi:10.1111/j.1442-2050.2004.00420.x 145   13 Cited 24 times in Scopus24 0
Aitken, Joanne F., Barbour, Andrew, Burmeister, Bryan, Taylor, Simon, Walpole, Euan, Australian Cancer Network, Smithers, Bernhard M. and Melanoma Guidelines Revision Working Party (2008) Clinical practice guidelines for the management of melanoma in Australia and New Zealand Sydney, Australia: Cancer Council Australia; Australian Cancer Network; Ministry of Health, New Zealand 509  
Burmeister, B. H., Smithers, B. M. and Denham, J. W. (1997) Combined modality therapy for carcinoma of the oesophagus: Current status and future directions. Medical Journal of Australia, 167 7: 349-350. 33   3 Cited 4 times in Scopus4
Burmeister, BH, Denham, JW, Obrien, M, Jamieson, GG, Gill, PG, Devitt, P, Yeoh, E, Hamilton, CS, Ackland, SP, Lamb, DS, Spry, NA, Joseph, DJ, Atkinson, C and Walker, QJ (1995) Combined-Modality Therapy for Esophageal-Carcinoma - Preliminary-Results From a Large Australasian Multicenter Study. International Journal of Radiation Oncology Biology Physics, 32 4: 997-1006. doi:10.1016/0360-3016(94)00449-U 8   44 0
Lamb, DS, Burmeister, BH and Denham, JW (1996). Combined modality treatment for carcinoma oesophagus - Experience of the Trans-Tasman Radiation Oncology Group. In: British Journal of Cancer. , , (37-37). . 6   0
Rodrigues, George, Macbeth, Fergus, Burmeister, Bryan, Kelly, Karie-Lynn, Bezjak, Andrea, Langer, Corey, Hahn, Carol and Movsas, Benjamin (2012) Consensus Statement on Palliative Lung Radiotherapy: Third International Consensus Workshop on Palliative Radiotherapy and Symptom Control. Clinical Lung Cancer, 13 1: 1-5. doi:10.1016/j.cllc.2011.04.004 25   8 Cited 10 times in Scopus10 2
Foote, M. C., Burmeister, B., Burmeister, E., Bayley, G. and Smithers, B. M. (2008) Desmoplastic melanoma: the role of radiotherapy in improving local control. Australian and New Zealand Journal of Surgery, 78 4: 273-276. doi:10.1111/j.1445-2197.2008.04436.x 103   20 Cited 21 times in Scopus21 1
Purcell, A., Fleming, J., Bennett, S., Burmeister, B. and Haines, T. (2010) Determining the minimal clinically important difference criteria for the multidimensional fatigue inventory in a radiotherapy population. Supportive Care In Cancer, 18 3: 307-315. doi:10.1007/s00520-009-0653-z 104   15 Cited 18 times in Scopus18 0
Pryor, D.I., Burmeister, E., Burmeister, B.H., Poulsen, M.G. and Porceddu, S.V. (2011) Distinct patterns of stomatitis with concurrent cetuximab and radiotherapy for head and neck squamous cell carcinoma. Oral Oncology, 47 10: 984-987. doi:10.1016/j.oraloncology.2011.07.023 35   1 Cited 2 times in Scopus2 0
Barbour, Andrew, Smithers, Bernard Mark, Burmeister, Bryan, Zalcberg, John Raymond, Spry, Nigel, Smith, Garrett, Wilson, Kate, Roff, Kate, Yip, Sonia and Walpole, Euan Thomas (2012). DOCTOR: A randomized phase II trial of preoperative cisplatin, 5-fluorouracil, and docetaxel with or without radiotherapy based on poor early response to standard chemotherapy for resectable adenocarcinoma of the esophagus and/or OG junction. In: 2012 ASCO Annual Meeting. 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, Il United States, (). 01-06 June 2012. 110   0
Ngan, SYK, Burmeister, BH, Fisher, R, Rischin, D, Schache, DJ, Kneebone, A, MacKay, JR, Joseph, D, Bell, A and Goldstein, D (2001) Early toxicity from preoperative radiotherapy with continuous infusion 5-fluorouracil for resectable adenocarcinoma of the rectum: A phase II trial for the Trans-Tasman Radiation Oncology Group. International Journal of Radiation Oncology Biology Physics, 50 4: 883-887. doi:10.1016/S0360-3016(01)01536-X 34   28 Cited 37 times in Scopus37 0
Pryor, David I., Porceddu, Sandro V., Scuffham, Paul A., Whitty, Jennifer A., Thomas, Paul A. and Burmeister, Bryan H. (2013) Economic analysis of FDG-PET-guided management of the neck after primary chemoradiotherapy for node-positive head and neck squamous cell carcinoma. Head and Neck, 35 9: 1287-1294. doi:10.1002/hed.23108 17   3 Cited 3 times in Scopus3 1
Pryor, David I., Porceddu, Sandro V., Burmeister, Bryan H., Guminski, Alex, Thomson, Damien B., Shepherdson, Kristine and Poulsen, Michael (2009) Enhanced toxicity with concurrent cetuximab and radiotherapy in head and neck cancer. Radiotherapy and Oncology, 90 2: 172-176. doi:10.1016/j.radonc.2008.09.018 48   49 Cited 56 times in Scopus56 0
Peters, Peter, Repanos, Costa, Earnshaw, James, Stark, Patrick, Burmeister, Bryan, McGuire, Lloyd, Jeavons, Susanne and Coman, William B. (2010) Epithelial-myoepithelial carcinoma of the tongue base: A case for the case-report and review of the literature. Head and Neck Oncology, 2 4: . doi:10.1186/1758-3284-2-4 23   0 Cited 4 times in Scopus4 0
Smithers, Bernard Mark, Thomas, Janine M. and Burmeister, Bryan H. (2013). Esophagus carcinoma surveillance counter: Australia. In Frank Johnson, Yoshihiko Maehara, George P. Browman, Julie A. Margenthaler, Riccardo A. Audisio, John F. Thompson, David Y. Johnson, Craig C. Earle and Katerine S. Virgo (Ed.), Patient Surveillance after Cancer Treatment (pp. 97-100) New York, United States: Humana Press. doi:10.1007/978-1-60327-969-7_17 24   0
Denham, JW, Burmeister, BH, Lamb, DS, Spry, NA, Joseph, DJ, Hamilton, CS, Yeoh, E, OBrien, P and Walker, QJ (1996) Factors influencing outcome following radio-chemotherapy for oesophageal cancer. Radiotherapy and Oncology, 40 1: 31-43. doi:10.1016/0167-8140(96)01762-8 9   40 Cited 41 times in Scopus41 0
Burmeister, B., Walpole, E. T., Burmeister, E., Thomas, J., Thomson, D. B., Harvey, J., Smithers, B. M. and Gotley, D. C. (2005) Feasibility of chemoradiation therapy with protracted infusion of 5-fluorouracil for esophageal cancer patients not suitable for cisplatin. International Journal of Clinical Oncology, 10 4: 256-261. doi:10.1007/s10147-005-0506-9 56   Cited 9 times in Scopus9 0
Porceddu, Sandro V., Rosser, Brenda, Burmeister, Bryan H., Jones, Mark, Hickey, Brigid, Baumann, Kacy, Gogna, Kumar, Pullar, Andrew, Poulsen, Michael and Holt, Tanya (2007) Hypofractionated radiotherapy for the palliation of advanced head and neck cancer in patients unsuitable for curative treatment - "hypo trial". Radiotherapy and Oncology, 85 3: 456-462. doi:10.1016/j.radonc.2007.10.020 138   22 Cited 32 times in Scopus32 0
Porceddu, Sandro V., Rosser, Brenda, Burmeister, Bryan H., Jones, Mark, Hickey, Brigid, Baumann, Kacy, Gogna, Kumar, Pullar, Andrew, Poulsen, Michael and Holt, Tanya (2008) Hypofractionated radiotherapy for the palliation of advanced head and neck cancer in patients unsuitable for curative treatment - "hypo trial" - Authors letter of reply. Radiotherapy and Oncology, 87 2: 309-309. doi:10.1016/j.radonc.2008.03.015 93   0 Cited 0 times in Scopus0 0
Dwyer, P., Hickey, B., Burmwister, E. and Burmeister, B. (2010) Hypofractionated whole breast radiotherapy : Impact on depatmental waiting times and cost. Journal of Medical Imaging and Radiation Oncology, 54 3: 229-234. doi:10.1111/j.1754-9485.2010.02163.x 31   12 Cited 14 times in Scopus14 0

Page 1 of 3

Result Pages:    1 2 3  next › last »